Your session is about to expire
← Back to Search
Effect of Modified Time-restricted Feeding in Preventing Progression of Non-Alcoholic Fatty Liver Disease (NAFLD).
N/A
Waitlist Available
Led By Essam M Imseis, MD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
* Motivated obese fatty liver patients aged 8 -18yrs with ALT \>80
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
The purpose of the study is to examine the effects of modified time-restricted feeding and conventional dietary approaches in motivated obese fatty liver patients on biochemical markers, imaging studies, and anthropometric measurements.
Eligible Conditions
- Non-alcoholic Fatty Liver Disease
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Modified Time-restricted FeedingExperimental Treatment3 Interventions
Group II: Conventional dietActive Control3 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Physical activity
2011
Completed Phase 2
~4740
Find a Location
Who is running the clinical trial?
The University of Texas Health Science Center, HoustonLead Sponsor
957 Previous Clinical Trials
348,082 Total Patients Enrolled
3 Trials studying Non-alcoholic Fatty Liver Disease
78 Patients Enrolled for Non-alcoholic Fatty Liver Disease
Essam M Imseis, MDPrincipal InvestigatorThe University of Texas Health Sciences Center in Houston